Relmada Therapeutics
RLMD
RLMD
87 hedge funds and large institutions have $263M invested in Relmada Therapeutics in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.79% less ownership
Funds ownership: 59.19% → 57.4% (-1.8%)
17% less capital invested
Capital invested by funds: $316M → $263M (-$53.7M)
Holders
87
Holding in Top 10
1
Calls
$5.55M
Puts
$785K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$6.25M | |
| 3 | +$5.24M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.75M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$3.26M |
Top Sellers
| 1 | -$29.9M | |
| 2 | -$7.33M | |
| 3 | -$6.81M | |
| 4 |
TA
Tiedemann Advisors
New York
|
-$1.78M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.52M |